These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Cognitive impairment in hodgkin lymphoma survivors. Trachtenberg E; Mashiach T; Ben Hayun R; Tadmor T; Fisher T; Aharon-Peretz J; Dann EJ Br J Haematol; 2018 Sep; 182(5):670-678. PubMed ID: 29974933 [TBL] [Abstract][Full Text] [Related]
4. Predictors of baseline cancer-related cognitive impairment in cancer patients scheduled for a curative treatment. Lycke M; Pottel L; Pottel H; Ketelaars L; Stellamans K; Van Eygen K; Vergauwe P; Werbrouck P; Goethals L; Schofield P; Boterberg T; Debruyne PR Psychooncology; 2017 May; 26(5):632-639. PubMed ID: 27338029 [TBL] [Abstract][Full Text] [Related]
5. Assessment of cognitive function in long-term Hodgkin lymphoma survivors, results based on data from a major treatment center in Hungary. Magyari F; Virga I; Simon Z; Miltényi Z; Illés A; Kósa K; Ivánka T; Berecz R; Égerházi A; Illés Á Support Care Cancer; 2022 Jun; 30(6):5249-5258. PubMed ID: 35274189 [TBL] [Abstract][Full Text] [Related]
6. Prevalence of cognitive impairment and its relation to mental health in Danish lymphoma survivors. Mariegaard J; Wenstrup J; Lim KZM; Bidstrup PE; von Heymann A; Johansen C; Knudsen GM; Law I; Specht L; Stenbæk DS Support Care Cancer; 2021 Jun; 29(6):3319-3328. PubMed ID: 33118105 [TBL] [Abstract][Full Text] [Related]
7. The distress thermometer predicts subjective, but not objective, cognitive complaints six months after treatment initiation in cancer patients. Lycke M; Lefebvre T; Pottel L; Pottel H; Ketelaars L; Stellamans K; Eygen KV; Vergauwe P; Werbrouck P; Goethals L; Schofield P; Boterberg T; Debruyne PR J Psychosoc Oncol; 2017; 35(6):741-757. PubMed ID: 28816636 [TBL] [Abstract][Full Text] [Related]
8. Neuropsychological profiles of breast cancer and brain tumor cohorts in Northeast Ontario, Canada. Mariani M; Collins MWG Support Care Cancer; 2018 Nov; 26(11):3801-3809. PubMed ID: 29774475 [TBL] [Abstract][Full Text] [Related]
9. Characterization of cancer survivors clustered by subjective and objective cognitive function scores. Goto T; Saligan LN; Juneau P; Gonsalves SG; Rio CJ; Graves LY; Von Ah D Cancer Med; 2024 Jun; 13(12):e7255. PubMed ID: 39185749 [TBL] [Abstract][Full Text] [Related]
10. The Experience of Cancer-Related Cognitive Impairment Across Common Cancers: Protocol for a Qualitative Systematic Review. Ibrar M; Rai HK; Main A; McCartney H; Maguire R; Rodriguez MAP JMIR Res Protoc; 2024 May; 13():e56888. PubMed ID: 38820581 [TBL] [Abstract][Full Text] [Related]
11. Cancer-related cognitive impairment: updates to treatment, the need for more evidence, and impact on quality of life-a narrative review. Yang Y; Von Ah D Ann Palliat Med; 2024 Sep; 13(5):1265-1280. PubMed ID: 39260437 [TBL] [Abstract][Full Text] [Related]
12. Association between psychological distress, subjective cognitive complaints and objective neuropsychological functioning in brain tumor patients. Pranckeviciene A; Deltuva VP; Tamasauskas A; Bunevicius A Clin Neurol Neurosurg; 2017 Dec; 163():18-23. PubMed ID: 29035741 [TBL] [Abstract][Full Text] [Related]
13. Evaluating subjective cognitive impairment in the adult epilepsy clinic: Effects of depression, number of antiepileptic medications, and seizure frequency. Feldman L; Lapin B; Busch RM; Bautista JF Epilepsy Behav; 2018 Apr; 81():18-24. PubMed ID: 29455082 [TBL] [Abstract][Full Text] [Related]
14. Cognitive impairment in patients with psoriasis: A matched case-control study. Innamorati M; Quinto RM; Lester D; Iani L; Graceffa D; Bonifati C J Psychosom Res; 2018 Feb; 105():99-105. PubMed ID: 29332640 [TBL] [Abstract][Full Text] [Related]
16. Cognitive Changes Related to Cancer Therapy. Vannorsdall TD Med Clin North Am; 2017 Nov; 101(6):1115-1134. PubMed ID: 28992858 [TBL] [Abstract][Full Text] [Related]
17. Cognitive deficits including executive functioning in relation to clinical parameters in paediatric MS patients. Wuerfel E; Weddige A; Hagmayer Y; Jacob R; Wedekind L; Stark W; Gärtner J PLoS One; 2018; 13(3):e0194873. PubMed ID: 29566099 [TBL] [Abstract][Full Text] [Related]
18. Cancer-related cognitive impairment and wellbeing in patients with newly diagnosed aggressive lymphoma compared to population norms and healthy controls: an exploratory study. Gates P; Dhillon HM; Krishnasamy M; Wilson C; Gough K Support Care Cancer; 2024 Mar; 32(4):238. PubMed ID: 38512692 [TBL] [Abstract][Full Text] [Related]